| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/11/2013 | CN102234258B Preparation method and application of sphaelactone |
| 12/11/2013 | CN102153538B Benzocyclodirivative |
| 12/11/2013 | CN102149713B Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 12/11/2013 | CN102125579B Novel application of 5-bit modified 2'deoxycytidine derivative or phosphate thereof in the preparation of medicaments |
| 12/11/2013 | CN102066353B Disubstituted phthalazine Hedgehog pathway antagonists |
| 12/11/2013 | CN102056591B Liposome medicament and preparation method and use thereof |
| 12/11/2013 | CN101918379B Platinum complex compound and utilization of the same |
| 12/11/2013 | CN101914161B Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
| 12/11/2013 | CN101869716B System for monitoring bacterial tumor treatment |
| 12/11/2013 | CN101861319B Benzazepinone compound |
| 12/11/2013 | CN101684123B Preparation method of 2-formamido thienopyridine derivatives and medical uses |
| 12/11/2013 | CN101669935B Drug combination containing prunetin and application thereof in drugs |
| 12/11/2013 | CN101405281B Inhibitors of the interaction between MDM2 and P53 |
| 12/11/2013 | CN101360746B Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors |
| 12/11/2013 | CN101278989B Method for extracting Thalictrum aquilegifolium total alkaloids and total saponins from Thalictrum aquilegifolium |
| 12/10/2013 | US8604067 ITE for cancer intervention and eradication |
| 12/10/2013 | US8604036 Pyridazinone derivatives |
| 12/10/2013 | US8604023 1,4-benzodiazepinone compounds and their use in treating cancer |
| 12/10/2013 | US8604021 Substituted arylamine compounds and methods of treatment |
| 12/10/2013 | US8603997 siRNA that inhibits WT1 gene expression and uses thereof |
| 12/10/2013 | US8603990 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation |
| 12/10/2013 | US8603985 Treatment or prevention of cancer and precancerous disorders |
| 12/10/2013 | US8603778 Anti-TNF antibodies, compositions, methods and uses |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | US8603482 Compositions and methods for cancer immunotherapy |
| 12/10/2013 | US8603481 Therapeutic agents for solid tumors |
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | US8603454 Cyclodextrin-based polymers for therapeutics delivery |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | CA2699611C Desaturase genes and uses thereof |
| 12/10/2013 | CA2698579C Desaturase genes and uses thereof |
| 12/10/2013 | CA2688472C Biphenylcarboxamide derivatives as hedgehog pathway modulators |
| 12/10/2013 | CA2656851C Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 12/10/2013 | CA2656825C Method of treatment and agents useful for same |
| 12/10/2013 | CA2650206C Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same |
| 12/10/2013 | CA2605272C Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 12/10/2013 | CA2536015C Modified oligonucleotides for telomerase inhibition |
| 12/10/2013 | CA2495442C Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/10/2013 | CA2464700C Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 12/10/2013 | CA2443617C Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/10/2013 | CA2341349C Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| 12/05/2013 | WO2013181557A1 Targeting cancer cells and tissue using filamentous plant virus particles |
| 12/05/2013 | WO2013181543A1 High-affinity monoclonal antibodies to glypican-3 and use thereof |
| 12/05/2013 | WO2013181462A1 Use of amg 900 for the treatment of cancer |
| 12/05/2013 | WO2013181326A1 Generation of functional and durable endothelial cells from human amniotic fluid-derived cells |
| 12/05/2013 | WO2013181251A1 Crizotinib hydrochloride salt in crystalline |
| 12/05/2013 | WO2013181228A1 Dna modifying fusion proteins and methods of use thereof |
| 12/05/2013 | WO2013180949A1 Substituted quinoline compounds and methods of use |
| 12/05/2013 | WO2013180462A1 A composition comprising the extract of pine tree leaf or the compounds isolated therefrom for the prevention and treatment of cancer disease by inhibiting hpv virus and the uses thereby |
| 12/05/2013 | WO2013180403A1 Process for preparing gefitinib and an intermediate used for preparing thereof |
| 12/05/2013 | WO2013180274A1 Chemotherapy selection method for stomach cancer patients |
| 12/05/2013 | WO2013180200A1 Target-tissue-specific antigen-binding molecule |
| 12/05/2013 | WO2013180183A1 Aromatic heterocyclic derivative and pharmaceutical |
| 12/05/2013 | WO2013180140A1 Dihydroorotic acid dehydrogenase inhibitor |
| 12/05/2013 | WO2013180128A1 4-[4-(5-membered aromatic heterocyclic carbonyl ureide)phenyloxy]quinoline derivative |
| 12/05/2013 | WO2013179248A1 Pharmaceutical compositions of pemetrexed |
| 12/05/2013 | WO2013179143A2 Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors |
| 12/05/2013 | WO2013179033A1 Pteridines as fgfr inhibitors |
| 12/05/2013 | WO2013178954A1 Improved organic-inorganic hybrid solid having a modified outer surface |
| 12/05/2013 | WO2013178821A1 Inhibitors of the notch signalling pathway and secretion for use in medicine |
| 12/05/2013 | WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives |
| 12/05/2013 | WO2013178581A1 Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients |
| 12/05/2013 | WO2013178565A1 Genotype- or phenotype-based drug formulation |
| 12/05/2013 | WO2013178320A1 Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide |
| 12/05/2013 | WO2013178079A1 Tumor vaccine and preparation method thereof |
| 12/05/2013 | WO2013178075A1 N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and antitumor application thereof |
| 12/05/2013 | WO2013178021A1 Pyrrole [2, 1-f][1, 2, 4] triazine derivative and antitumor effect thereof |
| 12/05/2013 | WO2013177983A1 Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof |
| 12/05/2013 | WO2013177949A1 Composition for alleviating toxic and side effect of chemotherapy on malignant tumor patients and application thereof |
| 12/05/2013 | WO2013177948A1 Application of composition in preparing health care product or medicine for preventing and treating leukopenia caused by radiotherapy and chemotherapy |
| 12/05/2013 | WO2013177633A1 Combination therapy involving a vascular disrupting agent and an agent which targets hypoxia |
| 12/05/2013 | WO2013154458A3 Monomolecular chimeric t-cell receptor to a carcinoembryonic antigen |
| 12/05/2013 | WO2013153479A3 Indole and indazole compounds that activate ampk |
| 12/05/2013 | WO2013153450A3 Coriolus versicolor extracts, methods of isolating biologically-active compounds, and uses thereof |
| 12/05/2013 | WO2013144737A3 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases |
| 12/05/2013 | WO2013136296A3 Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands |
| 12/05/2013 | WO2013134534A3 Solid state forms of cabazitaxel and processes for preparation thereof |
| 12/05/2013 | US20130323755 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 12/05/2013 | US20130323247 Treatment of acute lymphoblastic leukemia |
| 12/05/2013 | CA2875189A1 Genotype- or phenotype-based drug formulation |
| 12/05/2013 | CA2875145A1 Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide |
| 12/05/2013 | CA2874967A1 Pteridines as fgfr inhibitors |
| 12/05/2013 | CA2874905A1 Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients |
| 12/04/2013 | EP2669297A1 Humanized anti-egfr antibody l4-h3 and coding gene thereof |
| 12/04/2013 | EP2669292A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof |
| 12/04/2013 | EP2669289A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application |
| 12/04/2013 | EP2669267A1 Compositions and methods for treating hyperproliferative disorders |
| 12/04/2013 | EP2668973A1 Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| 12/04/2013 | EP2668961A1 Combined pharmaceutical preparation |
| 12/04/2013 | EP2668949A1 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
| 12/04/2013 | EP2668945A1 Genotype and phenotype-based medicinal formulations |
| 12/04/2013 | EP2668274A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors |
| 12/04/2013 | EP2668209A1 Antibodies selective for cells presenting egfr at high density |
| 12/04/2013 | EP2668190A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors |
| 12/04/2013 | EP2668189A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors |
| 12/04/2013 | EP2668188A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors |
| 12/04/2013 | EP2668184A1 Derivatives of azaindazole or diazaindazole type as medicament |